Menu Portal
Home Committees Programme Registration Conference Rules Review Policy
Submit Article
INTERNATIONAL EVENT
CONFERENCE UMSURA 2026

ICBLSB

The International Conference on Biomedical, Life Sciences and Biotechnology

THEME:

"Advancing Biomedical Research, Life Sciences and Biotechnology for a Sustainable Future"

Explore Tracks View Schedule

Submission Countdown

00 Days
00 Hours
00 Mins
00 Secs
Current Status: Phase 01: Call for Papers
Closing Deadline: Oct 03, 2026
Submit Paper Node
5 SCIENTIFIC TRACKS
Double-Blind PEER REVIEW PROCESS
7 CONFERENCE PHASES
Scopus-Indexed Publication Opportunity
Scholarly Hub

Welcome to ICBLSB International Conference

It is my great pleasure to welcome you to The International Conference on Biomedical, Life Sciences and Biotechnology (ICBLSB 2026), hosted by Universitas Muhammadiyah Surabaya (UMSur), Indonesia.

Under the theme "Advancing Biomedical Research, Life Sciences and Biotechnology for a Sustainable Future," this conference serves as an international platform for researchers, academicians, healthcare professionals, scientists, industry experts, and policymakers to exchange knowledge, present cutting-edge research, and foster interdisciplinary collaboration in addressing global challenges through scientific innovation.

ICBLSB 2026 embraces five scientific tracks: Biomedical Sciences, Pharmaceutical Sciences, Biological Sciences, Biotechnology and Bioengineering, and Bioinformatics and Biomedical Informatics. These tracks reflect our commitment to advancing scientific excellence and promoting innovative solutions that contribute to human health, environmental sustainability, and technological development.

The conference proceedings present original research papers that have undergone a rigorous double-blind peer-review process to ensure scientific quality, originality, and academic integrity. Accepted and presented papers will be considered for publication in BIO Web of Conferences, subject to the conference peer-review process, editorial evaluation, and the publisher's acceptance policy.

On behalf of Universitas Muhammadiyah Surabaya, I sincerely thank all authors, keynote speakers, reviewers, members of the scientific committee, sponsors, and participants for their valuable contributions to the success of this conference. I hope this event will strengthen international research collaboration, encourage the exchange of ideas, and inspire innovations that create meaningful impacts for society.

I wish you a productive conference and an enjoyable experience at ICBLSB 2026.

Thank you.

Rektor UM Surabaya

Prof. Dr. Mundakir, S.Kep., Ns., M.Kep. FISQua.

Rector UM Surabaya

Taxonomy Structure

Theme, Focus and Scope

Review articles and purely theoretical papers are strictly outside the scope of this volume.

TRACK 01

Biomedical Sciences

Biomedical Sciences focuses on fundamental, translational, and clinical research that advances the understanding of biological processes, disease mechanisms, diagnostics, therapeutics, and clinical applications to improve human health. This track welcomes original research in a broad range of biomedical disciplines, including clinical medicine, clinical epidemiology, clinical research, translational medicine, precision medicine, molecular medicine, clinical biochemistry, clinical immunology, molecular pathology, medical diagnostics, clinical microbiology, pathophysiology, human physiology, cancer biology, regenerative medicine, stem cell research, clinical genomics, maternal and neonatal health, clinical nursing, and rehabilitation sciences. Interdisciplinary studies that integrate biomedical sciences with emerging technologies and innovative healthcare solutions are also encouraged.

CLINICAL RESEARCH
TRACK 02

Pharmaceutical Sciences

Pharmaceutical Sciences encompasses fundamental and applied research in pharmaceutical sciences, focusing on the discovery, development, evaluation, and safe use of therapeutic agents to improve human health. This track welcomes original research covering a wide range of pharmaceutical disciplines, including pharmacology, clinical pharmacology, drug discovery, drug delivery systems, pharmaceutical technology, pharmaceutical analysis, pharmacokinetics, pharmacodynamics, pharmacovigilance, biopharmaceuticals, clinical pharmacy, natural products, herbal medicines, and clinical drug development. Interdisciplinary research integrating pharmaceutical sciences with biotechnology, biomedical innovation, and advanced drug development technologies is also encouraged.

DRUG DISCOVERY
TRACK 03

Biological Sciences

Biological Sciences focuses on fundamental and applied research that advances the understanding of living organisms, biological systems, and their interactions across molecular, cellular, organismal, and ecosystem levels. This track welcomes original research in a broad range of biological disciplines, including cell biology, molecular biology, molecular genetics, functional genomics, microbiology, physiology, proteomics, metabolomics, systems biology, evolutionary biology, biodiversity, ecology, environmental biology, and conservation biology. Interdisciplinary studies that integrate biological sciences with biotechnology, biomedical research, environmental sustainability, and emerging life science technologies are also encouraged.

LIFE SCIENCES
TRACK 04

Biotechnology and Bioengineering

Biotechnology and Bioengineering focuses on interdisciplinary research that integrates biological sciences, engineering, and technological innovation to develop advanced solutions for biomedical, healthcare, and life science applications. This track welcomes original research in a wide range of biotechnology and bioengineering disciplines, including medical biotechnology, molecular biotechnology, cellular biotechnology, biopharmaceutical biotechnology, tissue engineering, biomaterials, biomedical engineering, biosensors, biomedical devices, synthetic biology, molecular engineering, regenerative engineering, and bioinstrumentation. Interdisciplinary studies that combine biotechnology, bioengineering, artificial intelligence, advanced materials, and emerging technologies to address global health and sustainability challenges are also encouraged.

BIOTECHNOLOGY
TRACK 05

Bioinformatics and Biomedical Informatics

Bioinformatics and Biomedical Informatics focuses on computational approaches supporting biomedical and life science research through biological data analysis, biomedical informatics, and artificial intelligence. This track welcomes original research in a broad range of computational disciplines, including bioinformatics, computational biology, biomedical informatics, biomedical data science, biomedical signal processing, medical image analysis, clinical decision support, genomic data analysis, multi-omics data analysis, computational systems biology, AI-assisted diagnostics, and machine learning for biomedical research.

COMPUTATIONAL BIOLOGY
Academic Schedule

Important Dates

Please note the timeline and important dates for ICBLSB 2026 paper submissions. The entire selection process is conducted via double-blind peer review.

Phase 01
01

Phase 01

Full Paper Submission

Timeline Date:

July 01 – August 15, 2026

Authors submit original full papers through the conference submission system in accordance with the author guidelines and manuscript template.

Phase 02
02

Phase 02

Double-Blind Peer Review

Timeline Date:

August 16 – September 07, 2026

Submitted manuscripts undergo a rigorous double-blind peer-review process conducted by independent reviewers to ensure scientific quality and relevance.

Phase 03
03

Phase 03

Review Result Notification

Timeline Date:

September 09, 2026

Authors receive the editorial decision together with reviewers' comments and recommendations for revision, if applicable.

Phase 04
04

Phase 04

Revision & Camera-Ready Submission

Timeline Date:

September 10 – September 20, 2026

Authors submit revised manuscripts and the final camera-ready version after addressing all reviewer comments.

Phase 05
05

Phase 05

Acceptance Letter & Registration

Timeline Date:

September 22, 2026

Accepted authors receive the official acceptance letter and complete the conference registration process.

Phase 06
06

Phase 06

Presentation File Submission

Timeline Date:

September 23 – September 30, 2026

Authors upload their presentation slides and, for online presenters, an optional pre-recorded presentation video before the conference.

Main Event
07

Conference Day

Conference Day

Timeline Date:

October 07, 2026

Authors present their research findings, participate in scientific discussions, and engage with the international research community during the conference.

* All dates are based on WIB (Western Indonesian Time) and may subject to slight adjustment by the steering committee.

Keynote Speakers

Prof. Dr. Mundakir, M.Kep.

Prof. Dr. Mundakir, M.Kep.

Rector

Universitas Muhammadiyah Surabaya

ORCID Scholar Sc
Prof. Dr. Jan (J.L.) Nouwen, MD., PhD

Prof. Dr. Jan (J.L.) Nouwen, MD., PhD

Clinical Microbiology & Infectious Diseases

Erasmus MC Rotterdam, Netherlands

ORCID Scholar Sc
Professor Ming-Yu Lung

Professor Ming-Yu Lung

Natural Products & Bioactive Compounds

Minghsin University of Science and Technology Taiwan

ORCID Scholar Sc
Dr. Alireza Mirbagheri

Dr. Alireza Mirbagheri

Biomedical Engineering & Medical Robotics

Tehran University of Medical Sciences, Iran

ORCID Scholar Sc
Conference Progress

Conference Timeline & Flow

Submission & Review

1
Account Registration Authors create an account through the Submit Article button to access the conference submission system (OJS)
2
Full Paper Submission Authors submit the original full paper using the official conference template and select the most appropriate scientific track.
3
Double-Blind Peer Review All submitted manuscripts undergo a rigorous double-blind peer-review process conducted by independent reviewers to ensure scientific quality and relevance.

Revision & Conference

4
Revision & Camera-Ready Submission Authors revise their manuscripts based on reviewers' comments and submit the final camera-ready version.
5
Acceptance Letter & Registration Accepted authors receive the official Letter of Acceptance (LoA) and complete the conference registration process.
6
Presentation & Publication Authors present their research during the conference. Accepted and presented papers will be considered for publication in BIO Web of Conferences, subject to the conference peer-review process, editorial evaluation, and the publisher's acceptance criteria.
Start Paper Submission

Academic Partners

TUMS Signature BLUE
IEEE Logo
Erasmus MC Logo